Individual #00025130

ID_report -
Reference PubMed: Hansen 2013
Remarks Family with three girls with autosomal recessive hyperphosphatasia with mental retardation-3.
Gender F
Consanguinity yes
Country Syria
Population African
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases HPMRS3
Owner name Philippe Campeau
Database submission license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 InternationalCreative Commons License
Created by Philippe Campeau
Date created 2014-12-05 19:58:41 +01:00 (CET)
Date last edited 2018-08-22 22:37:26 +02:00 (CEST)


Phenotypes

hyperphosphatasia, with mental retardation syndrome, type 3 (HPMRS-3, glycosylphosphatidylinositol deficiency, type 8 (GPIBD-8)) (HPMRS3;GPIBD8)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000021241 The sisters of the first branch had an IQ below 35. Their motor development was severely delayed, and they had pronounced muscular weakness, hypotonia, and strabismus. Sleep patterns of both girls were disordered. Serum ALP activity was elevated. CT showed atrophy and increased gyration in both girls. Elder sister showed signs of Dandy-Walker malformation. Both girls had stature and head circumference belos the 5th percentile. Parents had also HC below the 5th percentile. The third girl, of the second branch, had hypotonia at birth. Motor development and language were severely delayed. Brain CT showed atrophy. Muscle atrophy was found by biopsy. - - Familial, autosomal recessive - - - - - Philippe Campeau



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000025131 DNA SEQ-NG - - PGAP2 1 Philippe Campeau
0000025132 DNA SEQ-NG - - PGAP2 Not yet submitted Philippe Campeau



Variants

1 entry on 1 page. Showing entry 1.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
11 Both (homozygous) +/. - pathogenic g.3845243A>G g.3824013A>G - - PGAP2_000001 Rescue experiments with the altered proteins in PGAP2-deficient Chinese hamster ovary cell lines showed less expression of cell-surface GPI-anchored proteins DAF and CD59 than of the wild-type protein. atient lymphoblastoid cells showed essentially normal expression of the GPI-anchored proteins supporting a hypomorphic effect of this mutation. PubMed: Hansen et al. 2013 - - Germline yes - - - - Philippe Campeau PGAP2 - - - - - NM_001256240.1:c.296A>G - r.(?) p.(Tyr99Cys) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.